- Home
- OBE vs PRME Comparison
OBE vs PRME Comparison
Compare OBE & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBE
- PRME
- Stock Information
- Founded
- OBE 1979
- PRME 2019
- Country
- OBE Canada
- PRME United States
- Employees
- OBE N/A
- PRME N/A
- Industry
- OBE Oil & Gas Production
- PRME Medicinal Chemicals and Botanical Products
- Sector
- OBE Energy
- PRME Health Care
- Exchange
- OBE Nasdaq
- PRME Nasdaq
- Market Cap
- OBE 402.1M
- PRME 379.1M
- IPO Year
- OBE N/A
- PRME 2022
- Fundamental
- Price
- OBE $6.01
- PRME $2.97
- Analyst Decision
- OBE Strong Buy
- PRME Strong Buy
- Analyst Count
- OBE 1
- PRME 9
- Target Price
- OBE $14.00
- PRME $13.13
- AVG Volume (30 Days)
- OBE 486.6K
- PRME 1.0M
- Earning Date
- OBE 02-25-2025
- PRME 03-04-2025
- Dividend Yield
- OBE N/A
- PRME N/A
- EPS Growth
- OBE N/A
- PRME N/A
- EPS
- OBE 1.05
- PRME N/A
- Revenue
- OBE $516,155,298.00
- PRME $800,000.00
- Revenue This Year
- OBE $23.37
- PRME N/A
- Revenue Next Year
- OBE $5.83
- PRME $477.62
- P/E Ratio
- OBE $5.19
- PRME N/A
- Revenue Growth
- OBE 3.06
- PRME N/A
- 52 Week Low
- OBE $4.87
- PRME $2.25
- 52 Week High
- OBE $9.07
- PRME $9.77
- Technical
- Relative Strength Index (RSI)
- OBE 63.68
- PRME 53.25
- Support Level
- OBE $5.25
- PRME $2.25
- Resistance Level
- OBE $6.18
- PRME $3.36
- Average True Range (ATR)
- OBE 0.24
- PRME 0.23
- MACD
- OBE 0.09
- PRME 0.07
- Stochastic Oscillator
- OBE 85.54
- PRME 64.41
About OBE Obsidian Energy Ltd.
Obsidian Energy Ltd is an intermediate-sized oil and gas producer with strategic assets in Alberta. It operates in a single reporting segment that is exploration, development, and holding an interest in oil and natural gas properties and related production infrastructure in the Western Canada Sedimentary Basin. The company generates the majority of the revenue from the Crude oil sale.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.